Anup Amatya

1.4k total citations
49 papers, 698 citations indexed

About

Anup Amatya is a scholar working on Statistics and Probability, Oncology and General Health Professions. According to data from OpenAlex, Anup Amatya has authored 49 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Statistics and Probability, 9 papers in Oncology and 8 papers in General Health Professions. Recurrent topics in Anup Amatya's work include Statistical Methods and Bayesian Inference (12 papers), Statistical Methods in Clinical Trials (11 papers) and Statistical Methods and Inference (5 papers). Anup Amatya is often cited by papers focused on Statistical Methods and Bayesian Inference (12 papers), Statistical Methods in Clinical Trials (11 papers) and Statistical Methods and Inference (5 papers). Anup Amatya collaborates with scholars based in United States, Türkiye and Switzerland. Anup Amatya's co-authors include Robert D. Gibbons, Dulal K. Bhaumik, Hakan Demirtaş, Eloise Kaizar, Sharon‐Lise T. Normand, Brian Neelon, Joel B. Greenhouse, Richard Pazdur, Kwan Hur and J. John Mann and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Statistical Association and PLoS ONE.

In The Last Decade

Anup Amatya

49 papers receiving 680 citations

Peers

Anup Amatya
Ellie Siden Canada
Perrine Janiaud United States
Graham Wheeler United Kingdom
Perrine Créquit France
Shande Chen United States
Babak Choodari‐Oskooei United Kingdom
Chi–Rong Li Taiwan
Alexandre Vivot France
Lueping Zhao United States
Sangita Kulathinal Finland
Ellie Siden Canada
Anup Amatya
Citations per year, relative to Anup Amatya Anup Amatya (= 1×) peers Ellie Siden

Countries citing papers authored by Anup Amatya

Since Specialization
Citations

This map shows the geographic impact of Anup Amatya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anup Amatya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anup Amatya more than expected).

Fields of papers citing papers by Anup Amatya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anup Amatya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anup Amatya. The network helps show where Anup Amatya may publish in the future.

Co-authorship network of co-authors of Anup Amatya

This figure shows the co-authorship network connecting the top 25 collaborators of Anup Amatya. A scholar is included among the top collaborators of Anup Amatya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anup Amatya. Anup Amatya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casak, Sandra J., Vaibhav Kumar, Chi Song, et al.. (2024). FDA Approval Summary: Durvalumab and Pembrolizumab, Immune Checkpoint Inhibitors for the Treatment of Biliary Tract Cancer. Clinical Cancer Research. 30(16). 3371–3377. 7 indexed citations
2.
Mehta, Gautam U., Paz J. Vellanki, Yi Ren, et al.. (2024). FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations. The Oncologist. 29(8). 667–671. 10 indexed citations
3.
Akinboro, Oladimeji, Nicole Drezner, Anup Amatya, et al.. (2023). US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 41(17). 3249–3259. 23 indexed citations
4.
Shah, Mirat, Christy Osgood, Anup Amatya, et al.. (2022). FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer. Clinical Cancer Research. 28(24). 5249–5253. 56 indexed citations
5.
Ionan, Alexei, James Travis, Anup Amatya, et al.. (2022). Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER. Therapeutic Innovation & Regulatory Science. 57(3). 436–444. 10 indexed citations
6.
Amatya, Anup, et al.. (2020). Why nurses stay: Analysis of the registered nurse workforce and the relationship to work environments. Applied Nursing Research. 55. 151316–151316. 30 indexed citations
7.
8.
McDonald, Jill A., Anup Amatya, & Charlotte C. Gard. (2019). Multi-level Drivers of Disparities in Hispanic Cesarean Delivery Rates in US-Mexico Border States. Journal of Racial and Ethnic Health Disparities. 7(2). 238–250. 5 indexed citations
9.
Amatya, Anup, et al.. (2019). Using simulations to advance clinical reasoning. Applied Nursing Research. 47. 63–70. 8 indexed citations
10.
McDonald, Jill A., et al.. (2018). Trends in Hispanic and non-Hispanic white cesarean delivery rates on the US-Mexico border, 2000-2015. PLoS ONE. 13(9). e0203550–e0203550. 5 indexed citations
11.
Amatya, Anup & Hakan Demirtaş. (2016). Concurrent generation of multivariate mixed data with variables of dissimilar types. Journal of Statistical Computation and Simulation. 86(18). 3595–3607. 3 indexed citations
12.
McDonald, Jill A., et al.. (2015). First Trimester Initiation of Prenatal Care in the US-Mexico Border Region. Medical Care. 53(8). 700–707. 7 indexed citations
13.
Amatya, Anup, Dulal K. Bhaumik, Sharon‐Lise T. Normand, et al.. (2014). Likelihood-Based Random-Effect Meta-Analysis of Binary Events. Journal of Biopharmaceutical Statistics. 25(5). 984–1004. 3 indexed citations
14.
Amatya, Anup, et al.. (2014). Breast Cancer Prevention Knowledge, Beliefs, and Information Sources Between Non-Hispanic and Hispanic College Women for Risk Reduction Focus. Journal of Community Health. 40(1). 124–130. 12 indexed citations
15.
16.
Gann, Peter H., et al.. (2013). Development of a Nuclear Morphometric Signature for Prostate Cancer Risk in Negative Biopsies. PLoS ONE. 8(7). e69457–e69457. 13 indexed citations
17.
Amatya, Anup, et al.. (2013). Breast Cancer Prevention Knowledge, Attitudes, and Behaviors Among College Women and Mother–Daughter Communication. Journal of Community Health. 38(3). 560–568. 26 indexed citations
18.
Bhaumik, Dulal K., Anup Amatya, Sharon‐Lise T. Normand, et al.. (2012). Meta-Analysis of Rare Binary Adverse Event Data. Journal of the American Statistical Association. 107(498). 555–567. 101 indexed citations
19.
Gibbons, Robert D., Anup Amatya, C. Hendricks Brown, et al.. (2010). Post-Approval Drug Safety Surveillance. Annual Review of Public Health. 31(1). 419–437. 47 indexed citations
20.
Gibbons, Robert D., Eisuke Segawa, George Karabatsos, et al.. (2008). Mixed‐effects Poisson regression analysis of adverse event reports: The relationship between antidepressants and suicide. Statistics in Medicine. 27(11). 1814–1833. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellie Siden Breakdown of academic impact, for papers by Perrine Janiaud Breakdown of academic impact, for papers by Graham Wheeler Breakdown of academic impact, for papers by Perrine Créquit Breakdown of academic impact, for papers by Shande Chen Breakdown of academic impact, for papers by Babak Choodari‐Oskooei Breakdown of academic impact, for papers by Chi–Rong Li Breakdown of academic impact, for papers by Alexandre Vivot Breakdown of academic impact, for papers by Lueping Zhao Breakdown of academic impact, for papers by Sangita Kulathinal
Rankless by CCL
2026